These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36338570)

  • 21. Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients.
    Göbel A; Kuhlmann JD; Link T; Wimberger P; Link-Rachner C; Thiele S; Dell'Endice S; Furesi G; Breining D; Rauner M; Hofbauer LC; Rachner TD
    J Bone Oncol; 2019 Jun; 16():100237. PubMed ID: 31011525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer.
    Theodoraki MN; Lorenz K; Lotfi R; Fürst D; Tsamadou C; Jaekle S; Mytilineos J; Brunner C; Theodorakis J; Hoffmann TK; Laban S; Schuler PJ
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():194-201. PubMed ID: 28578124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteopontin deficiency protects mice from Dextran sodium sulfate-induced colitis.
    Zhong J; Eckhardt ER; Oz HS; Bruemmer D; de Villiers WJ
    Inflamm Bowel Dis; 2006 Aug; 12(8):790-6. PubMed ID: 16917234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil-Derived Semaphorin 4D Induces Inflammatory Cytokine Production of Endothelial Cells via Different Plexin Receptors in Kawasaki Disease.
    Huang J; Wu S; Cao S; Zhu X; Zhang S
    Biomed Res Int; 2020; 2020():6663291. PubMed ID: 33381571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the efficacy of osteopontin expression as a prognostic marker in oral squamous cell carcinoma in the Indian subpopulation.
    Ingale Y; Routray S; Kheur SM; Kheur M; Mohanty N
    J Oral Maxillofac Pathol; 2014 Sep; 18(Suppl 1):S11-5. PubMed ID: 25364158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
    Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
    Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomas.
    Shkeir O; Athanassiou-Papaefthymiou M; Lapadatescu M; Papagerakis P; Czerwinski MJ; Bradford CR; Carey TE; Prince ME; Wolf GT; Papagerakis S
    Head Neck; 2013 Nov; 35(11):1542-50. PubMed ID: 23322448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.
    Espinosa-Cotton M; Rodman Iii SN; Ross KA; Jensen IJ; Sangodeyi-Miller K; McLaren AJ; Dahl RA; Gibson-Corley KN; Koch AT; Fu YX; Badovinac VP; Laux D; Narasimhan B; Simons AL
    J Immunother Cancer; 2019 Mar; 7(1):79. PubMed ID: 30890189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: A pilot study.
    Aderhold C; Grobschmidt GM; Sauter A; Faber A; Hörmann K; Schultz JD
    Oncol Lett; 2014 Sep; 8(3):1112-1118. PubMed ID: 25120668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
    Jafarinia M; Sadeghi E; Alsahebfosoul F; Etemadifar M; Jahanbani-Ardakani H
    Int J Neurosci; 2020 May; 130(5):493-498. PubMed ID: 31795798
    [No Abstract]   [Full Text] [Related]  

  • 33. Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages.
    Shimizu S; Okuda N; Kato N; Rittling SR; Okawa A; Shinomiya K; Muneta T; Denhardt DT; Noda M; Tsuji K; Asou Y
    Arthritis Rheum; 2010 May; 62(5):1329-37. PubMed ID: 20155835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis.
    Tsuda T; Nishide M; Maeda Y; Hayama Y; Koyama S; Nojima S; Takamatsu H; Okuzaki D; Morita T; Nakatani T; Kato Y; Nakanishi Y; Futami Y; Suga Y; Naito Y; Konaka H; Satoh S; Naito M; Izumi M; Obata S; Nakatani A; Shikina T; Takeda K; Hayama M; Inohara H; Kumanogoh A
    J Allergy Clin Immunol; 2020 Mar; 145(3):843-854.e4. PubMed ID: 32035658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections.
    Avirović M; Matušan-Ilijaš K; Damante G; Fabrro D; Cerović R; Juretić M; Grahovac B; Jonjić N; Lučin K
    J Oral Pathol Med; 2013 Sep; 42(8):620-6. PubMed ID: 23438150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
    Van Tubergen E; Vander Broek R; Lee J; Wolf G; Carey T; Bradford C; Prince M; Kirkwood KL; D'Silva NJ
    Cancer; 2011 Jun; 117(12):2677-89. PubMed ID: 21656745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system.
    Vordermark D; Said HM; Katzer A; Kuhnt T; Hänsgen G; Dunst J; Flentje M; Bache M
    BMC Cancer; 2006 Aug; 6():207. PubMed ID: 16911785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokine (C-C motif) ligand 20, a potential biomarker for Graves' disease, is regulated by osteopontin.
    Li X; Qi Y; Ma X; Huang F; Guo H; Jiang X; Hong J; Lin D; Cui B; Ning G; Xu L; Wang S
    PLoS One; 2013; 8(5):e64277. PubMed ID: 23717583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis.
    Lavi H; Assayag M; Schwartz A; Arish N; Fridlender ZG; Berkman N
    PLoS One; 2017; 12(3):e0171945. PubMed ID: 28253271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease.
    Agnholt J; Kelsen J; Schack L; Hvas CL; Dahlerup JF; Sørensen ES
    Scand J Immunol; 2007 May; 65(5):453-60. PubMed ID: 17444956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.